Radiation Dose Management Market Report by Product & Services (Radiation Dose Management Solutions, and Radiation Dose Management Services), Modality (Computed Tomography, Fluoroscopy & Interventional Imaging, Mammography, and Nuclear Medicine), End-User (Hospitals, Ambulatory Care settings, and others), Country and Company Analysis 2023-2030

Radiation Dose Management Market Outlook

Global radiation dose management market is expected to reach US$ 785.81 Million by 2030, according to Renub Research. The goal of radiation dose management is to maintain radiation doses for patients undergoing medical imaging as low as reasonably achievable (ALARA), putting their safety first. This is essential for lowering the chance of cancer brought on by radiation exposure. Added patient safety, reduced costs, and greater diagnostic accuracy are all advantages. Choosing low-radiation modalities, maximizing imaging settings, and applying shielding are examples of implementation tactics. In addition to improving overall care during medical imaging, this method lowers the risk of cancer, increases diagnostic accuracy, lowers expenses, and improves patient safety.

Systems for dose management are employed for quality control, optimization, adherence to diagnostic reference levels, and patient exposure to ionization emissions. In compliance with regional and governmental regulations, dose management systems support the activities and responsibilities of radiation protection. They provide assistance to medical imaging specialists such as radiologists, doctors, and medical physics experts (MPE).

Between 2022 and 2030, the global radiation dose management market is anticipated to expand at a CAGR of 13.13%

Dosage optimization in pediatric radiology is challenging due to variations in body size and composition across different age groups. This is crucial, as children are more susceptible to the harmful effects of radiation. The National Cancer Institute reports that millions of CT scans are performed on children in the United States annually. However, most dosage data and trends are based on adult studies, leading to a growing trend of reducing radiation doses in pediatric imaging exams. In the United States, more than 80 Million computed tomography (CT) scans are performed each year, according to Harvard Medical School research. With procedures like CT angiography, colonography, and dual-energy and perfusion CT, these scanning techniques have had a significant impact on the field of medical diagnosis and therapy.

Excessive radiation exposure poses long-term health risks. Research by the National Institute of Health discovered that brain scan doses in the US were eight times higher than recommended limits. Concerns led the US FDA to recommend tailored protocols for manufacturers and imaging facilities. To enhance patient safety during CT scans, the FDA advises hospitals to establish dose adjustment standards, which are typically followed globally.

High-end CT systems are rapidly being used in the majority of hospitals and imaging facilities with innovative dose reduction technology. The burden of manual dose collection for CT conducted in a center is lessened by the dosage tracking software. This helps identify incorrect dose selection early on.So, the value of the global radiation dose management market was US$ 292.86 Million in 2022.

Radiation dose management solutions dominate the global market

Radiation Dose Management Solutions and Radiation Dose Management Services comprise the global radiation dose management market. The increasing use of medical imaging, driven by the rising incidence of chronic diseases and the availability of imaging modalities, exposes more patients to radiation. Simultaneously, growing awareness among patients and healthcare providers about the risks of radiation exposure creates a demand for solutions that minimize such risks. Moreover, healthcare providers are compelled to adopt radiation dose management solutions to comply with escalating regulatory requirements. Technological advancements have further improved the effectiveness and affordability of these solutions, contributing to their widespread adoption.

In the modality segment of the global radiation dose management market, computed tomography is anticipated to record the highest growth rate

By Modality, global radiation dose management is divided into Computed Tomography, fluoroscopy, interventional imaging, mammography, and Nuclear Medicine. Manufacturers integrate technology for accurate dose estimation in CT scans to mitigate radiation exposure. New CT equipment reduces doses using hardware and software. Bayer's Radimetric Enterprise Platform automates dose documentation with the MedradStellant CT injection system. Canon Medical Systems' Aquilion One/Genesis Edition CT captures the entire brain image with a low dose and reduced noise.

Nuclear medicine procedures utilize higher radiation doses due to the injection of radioactive isotopes. Managing radiation doses is crucial to minimizing cancer risks. The increasing use of nuclear medicine procedures, driven by new radiopharmaceuticals and awareness of their benefits, necessitates radiation dose management solutions to comply with regulatory requirements.

Hospitals lead the global radiation dose management market.

Based on End-User, the global radiation dose management market is fragmented into hospitals, ambulatory care settings, and others. Hospitals require radiation dose management solutions due to their central role in medical imaging and the wide range of procedures they perform. Strict regulatory requirements for low radiation doses drive the adoption of these solutions. Hospitals have the resources to invest in and implement effective radiation dose management programs, including financial and human resources.

United States dominates the radiation dose management market due to stringent legislative and accreditation requirements for reporting and optimizing radiation doses

The United States, Canada, Germany, the United Kingdom, France, Italy, the Netherlands, Spain, China, South Korea, Japan, India, Indonesia, Malaysia, Argentina, Brazil, Mexico, Colombia, Saudi Arabia, South Africa, Israel, Australia, and the UAE are the countries comprising the global radiation dose management market. The Recommendations for the Early Detection of Cancer from the American Cancer Society state that women between the ages of 40 and 54 should start getting regular mammograms around age 45. The demand for radiation dose management solutions is influenced by the adoption of cutting-edge technologies, stringent government regulations, and an elevated awareness of radiation hazards. In order to preserve their leadership in the radiation dose management market, major market participants make significant investments in R&D and standardization.

China's growing healthcare industry and increased investment in medical facilities drive the demand for radiation dose management solutions. Rising public awareness of radiation hazards and government initiatives, such as national guidelines and programs, further promote adoption. With a large pool of skilled professionals and a competitive labor market, China is expected to experience rapid growth in the radiation dose management market.

Key Players

Thermo Fisher Scientific Inc., Koninklijke Philips N.V., Mckesson Corporation, Cerner Corporation, and Bayer AG are few of the leading businesses vying for customers in the global radiation dose management market. Global firms now hold a majority of the market share in the radiation dose management sector, which is relatively competitive. Few new competitors are concentrating on product innovation and are entering the market as a result of the growing technical improvements.

Renub Research latest report “Global Radiation Dose Management Market, Product & Services (Radiation Dose Management Solutions, and Radiation Dose Management Services), Modality (Computed Tomography, Fluoroscopy & Interventional Imaging, Mammography, and Nuclear Medicine), End-User (Hospitals, Ambulatory Care settings, and others), Countries (United States, Canada, Germany, United Kingdom, France, Italy, Netherlands, Spain, China, South Korea, Japan, India, Indonesia, Malaysia, Argentina, Brazil, Mexico, Colombia, Australia, Saudi Arabia, UAE, Israel, and South Africa), Companies (Thermo Fisher Scientific Inc., Koninklijke Philips N.V., Mckesson Corporation, Cerner Corporation, and Bayer AG)” provides a detailed analysis of Global Radiation Dose Management Market.

Product & Services – Market has been covered from 2 viewpoints:

1.    Radiation Dose Management Solutions
2.    Radiation Dose Management Services

Modality – Market has been covered from 4 viewpoints:

1.    Computed Tomography
2.    Fluoroscopy & Interventional Imaging
3.    Mammography
4.    Nuclear Medicine

End-User – Market has been covered from 3 viewpoints:

1.    Hospitals
2.    Ambulatory Care settings
3.    Others

Countries – Market has been covered from 23 viewpoints:

1.    North America

1.1    United States
1.2    Canada
1.3    Mexico

2.    Latin America

2.1    Argentina
2.2    Brazil
2.3    Colombia

3.    Europe

3.1    Germany
3.2    United Kingdom
3.3    France
3.4    Italy
3.5    Netherlands
3.6    Spain

4.    Asia Pacific

4.1    China
4.2    South Korea
4.3    Japan
4.4    India
4.5    Indonesia
4.6    Malaysia
4.7    Australia

5.    Middle East & Africa

5.1    Saudi Arabia
5.2    UAE
5.3    Israel
5.4    South Africa

Company Insights:

•    Oveview
•    Recent Development
•    Sales Analysis

Company Analysis:

1.    Thermo Fisher Scientific Inc.,
2.    Koninklijke Philips N.V.,
3.    Mckesson Corporation, 
4.    Cerner Corporation
5.    Bayer AG

Report Details: